| Title |
European guidelines on managing adverse effects of medication for ADHD
|
|---|---|
| Published in |
European Child & Adolescent Psychiatry, November 2010
|
| DOI | 10.1007/s00787-010-0140-6 |
| Pubmed ID | |
| Authors |
J. Graham, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, R. W. Dittmann, M. Döpfner, R. Hamilton, C. Hollis, M. Holtmann, M. Hulpke-Wette, M. Lecendreux, E. Rosenthal, A. Rothenberger, P. Santosh, J. Sergeant, E. Simonoff, E. Sonuga-Barke, I. C. K. Wong, A. Zuddas, H.-C. Steinhausen, E. Taylor, (for the European Guidelines Group) |
| Abstract |
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical subspecialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 23% |
| Netherlands | 2 | 15% |
| Norway | 1 | 8% |
| Japan | 1 | 8% |
| Unknown | 6 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 69% |
| Practitioners (doctors, other healthcare professionals) | 4 | 31% |
Mendeley readers
The data shown below were compiled from readership statistics for 459 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 4 | <1% |
| Netherlands | 3 | <1% |
| United States | 2 | <1% |
| United Kingdom | 2 | <1% |
| Chile | 1 | <1% |
| Italy | 1 | <1% |
| France | 1 | <1% |
| Germany | 1 | <1% |
| Portugal | 1 | <1% |
| Other | 3 | <1% |
| Unknown | 440 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 67 | 15% |
| Student > Master | 63 | 14% |
| Student > Ph. D. Student | 54 | 12% |
| Student > Bachelor | 50 | 11% |
| Student > Doctoral Student | 34 | 7% |
| Other | 115 | 25% |
| Unknown | 76 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 121 | 26% |
| Psychology | 104 | 23% |
| Neuroscience | 26 | 6% |
| Agricultural and Biological Sciences | 22 | 5% |
| Social Sciences | 19 | 4% |
| Other | 67 | 15% |
| Unknown | 100 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2024.
All research outputs
#1,550,884
of 24,862,067 outputs
Outputs from European Child & Adolescent Psychiatry
#156
of 1,790 outputs
Outputs of similar age
#5,345
of 105,580 outputs
Outputs of similar age from European Child & Adolescent Psychiatry
#2
of 7 outputs
Altmetric has tracked 24,862,067 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,790 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,580 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.